We have a range of antacids tablets and a liquid format developed to bring you quick, lasting relief from your symptoms, so you can get on with your life. Rennie® acts directly on the cause of the problem, which is the acid in your stomach. Whether your problem is heartburn, indigestion or acid reflux, you'll find a product specifically designed to help you. Legal notice:
Bayer reserves the right
to remove posts, comments, pictures, or videos from our wall at its sole discretion when they are not consistent with our guidelines or the regulatory rules of our industry. We don't endorse any users' comments other than our own. However, this doesn't mean that we don't have to meet all the regulations that govern our industry. That's why we will remove any post that references a pharmaceutical brand from any company including Bayer, no matter if it is positive or negative. Products
Rennie® Peppermint
Rennie® Spearmint
Rennie® Aniseed
Rennie® Orange
Rennie® Duo Suspension
If you would like to report an Adverse Event please contact your physician or your pharmacist or email: zaadverseevents@bayer.com. If you have a quality complaint please contact your pharmacist or email: zaqualitycc@bayer.com
Rennie® Duo Oral Suspension
Each 10 ml contains Calcium carbonate 1 200 mg, Magnesium carbonate 140 mg, and Sodium alginate 300 mg. No. 41/11.4.3/0449. Always use as directed on the label. Bayer (Pty) Ltd. 27 Wrench Road, Isando, 1600, Gauteng, South Africa. No. 1968/011192/07. Tel: +27 11 921 5000. Digestif Rennie® Tablets
[S0] Digestif Rennie® Tablets. Each Tablet contains Calcium carbonate 680 mg and Magnesium carbonate 80 mg. No. E/11.4.3/533. Digestif Rennie® Aniseed Tablets
[S0] Digestif Rennie® Aniseed Tablets. No. 32/11.4.3/0568. Digestif Rennie® Orange Tablets
[S0] Digestif Rennie® Orange Tablets. No. 41/11.4.3/0772. Template Trade name & Dosage form
Proprietary name. approved name and quantity of each active ingredient (minimum legibility) . Registration number. Identify Discipline. Indications to use in accordance to discipline. This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use. This medicine is
(a) the proprietary name of such medicine
(b)(i) the approved name and quantity of each active ingredient of such medicine in lettering having minimum legibility: Provided that, in the case of a medicine containing only one active ingredient, such lettering shall be not less than one half the size of the largest lettering used for the said proprietary name;
(b)(ii) of a registered medicine, the registration number allocated to it in terms of section 15(5) of the Act
(c) in the case of a-(ii) complementary medicine-(aa) a statement identifying the discipline of the medicine where relevant;
(c) in the case of a-(ii) complementary medicine-(bb) an indication that the medicine must be used in accordance with the applicable complementary discipline and principles where relevant
(c) in the case of a-(ii) complementary medicine-(cc) if the medicine has not received registration with the Authority the following disclaimer: not intended to diagnose, treat, cure or prevent any disease. How to cite package insert. Please use the following format:
Product name [Package Insert]. Place of publication: Manufacturer’s name; Year of publication. Example
Albuterol [package insert]. West Roxbury, MA: Armstrong Pharmaceuticals, Inc.; 2007.
